David Hardick

Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors

Andrew R. Davies, David Hardick, Ian S. Blagbrough et al. · Neuropharmacology · 1999 · 246 citations

Life Sciences, Neuroscience, Pharmacology +14

3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

Yassir Younis, Frédèric Douelle, Tzu‐Shean Feng et al. · Journal of Medicinal Chemistry · 2012 · 134 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Novel Angular Benzophenazines:  Dual Topoisomerase I and Topoisomerase II Inhibitors as Potential Anticancer Agents

Nigel Vicker, Luke Burgess, Irina Chuckowree et al. · Journal of Medicinal Chemistry · 2002 · 133 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity

Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic et al. · Cancer Discovery · 2023 · 115 citations

Medicine, Immunology, Oncology +17

Glucose is a Precursor of 1-deoxynojirimycin and 1-deoxymannonojirimycin in Streptomyces subrutilus

David Hardick, D. W. Hutchinson, Sally J. Trew et al. · Tetrahedron · 1992 · 89 citations

Life Sciences, Biochemistry, Microbiology +9